Software - Application
Compare Stocks
2 / 10Stock Comparison
LPSN vs SPOK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
LPSN vs SPOK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Medical - Healthcare Information Services |
| Market Cap | $30M | $220M |
| Revenue (TTM) | $244M | $103M |
| Net Income (TTM) | $-67M | $11M |
| Gross Margin | 62.2% | 91.4% |
| Operating Margin | -9.6% | 13.2% |
| Forward P/E | — | 16.1x |
| Total Debt | $392M | $7M |
| Cash & Equiv. | $95M | $25M |
LPSN vs SPOK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| LivePerson, Inc. (LPSN) | 100 | 0.4 | -99.6% |
| Spok Holdings, Inc. (SPOK) | 100 | 103.4 | +3.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LPSN vs SPOK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
In this particular matchup, LPSN is outpaced on most metrics by others in the set.
SPOK carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.42, yield 12.2%
- Rev growth 1.5%, EPS growth 2.7%, 3Y rev CAGR 1.3%
- 13.2% 10Y total return vs LPSN's -97.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.5% revenue growth vs LPSN's -22.0% | |
| Quality / Margins | 10.3% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.42 vs LPSN's 2.05 | |
| Dividends | 12.2% yield; 5-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -28.1% vs LPSN's -80.6% | |
| Efficiency (ROA) | 5.2% ROA vs LPSN's -12.4%, ROIC 11.3% vs -6.6% |
LPSN vs SPOK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LPSN vs SPOK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SPOK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LPSN is the larger business by revenue, generating $244M annually — 2.4x SPOK's $103M. SPOK is the more profitable business, keeping 10.3% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, LPSN holds the edge at -19.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $244M | $103M |
| EBITDAEarnings before interest/tax | -$562,000 | $17M |
| Net IncomeAfter-tax profit | -$67M | $11M |
| Free Cash FlowCash after capex | -$43M | $26M |
| Gross MarginGross profit ÷ Revenue | +62.2% | +91.4% |
| Operating MarginEBIT ÷ Revenue | -9.6% | +13.2% |
| Net MarginNet income ÷ Revenue | -27.6% | +10.3% |
| FCF MarginFCF ÷ Revenue | -17.4% | +24.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -19.0% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +79.4% | -64.0% |
Valuation Metrics
LPSN leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $30M | $220M |
| Enterprise ValueMkt cap + debt − cash | $327M | $202M |
| Trailing P/EPrice ÷ TTM EPS | -0.20x | 14.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.09x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 8.72x |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 1.58x |
| Price / BookPrice ÷ Book value/share | — | 1.53x |
| Price / FCFMarket cap ÷ FCF | — | 8.74x |
Profitability & Efficiency
SPOK leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), SPOK scores 6/9 vs LPSN's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +7.3% |
| ROA (TTM)Return on assets | -12.4% | +5.2% |
| ROICReturn on invested capital | -6.6% | +11.3% |
| ROCEReturn on capital employed | -5.8% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | — | 0.05x |
| Net DebtTotal debt minus cash | $297M | -$18M |
| Cash & Equiv.Liquid assets | $95M | $25M |
| Total DebtShort + long-term debt | $392M | $7M |
| Interest CoverageEBIT ÷ Interest expense | 0.20x | — |
Total Returns (Dividends Reinvested)
SPOK leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPOK five years ago would be worth $16,082 today (with dividends reinvested), compared to $33 for LPSN. Over the past 12 months, SPOK leads with a -28.1% total return vs LPSN's -80.6%. The 3-year compound annual growth rate (CAGR) favors SPOK at 3.8% vs LPSN's -66.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -35.5% | -15.9% |
| 1-Year ReturnPast 12 months | -80.6% | -28.1% |
| 3-Year ReturnCumulative with dividends | -96.1% | +11.7% |
| 5-Year ReturnCumulative with dividends | -99.7% | +60.8% |
| 10-Year ReturnCumulative with dividends | -97.2% | +13.2% |
| CAGR (3Y)Annualised 3-year return | -66.1% | +3.8% |
Risk & Volatility
SPOK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SPOK is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPOK currently trades 55.0% from its 52-week high vs LPSN's 11.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.05x | 0.42x |
| 52-Week HighHighest price in past year | $21.60 | $19.31 |
| 52-Week LowLowest price in past year | $2.37 | $9.96 |
| % of 52W HighCurrent price vs 52-week peak | +11.6% | +55.0% |
| RSI (14)Momentum oscillator 0–100 | 41.2 | 41.3 |
| Avg Volume (50D)Average daily shares traded | 146K | 185K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
SPOK is the only dividend payer here at 12.18% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $15.00 |
| # AnalystsCovering analysts | — | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +12.2% |
| Dividend StreakConsecutive years of raises | — | 5 |
| Dividend / ShareAnnual DPS | — | $1.29 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.3% |
SPOK leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LPSN leads in 1 (Valuation Metrics).
LPSN vs SPOK: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is LPSN or SPOK a better buy right now?
For growth investors, Spok Holdings, Inc.
(SPOK) is the stronger pick with 1. 5% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). Spok Holdings, Inc. (SPOK) offers the better valuation at 14. 2x trailing P/E (16. 1x forward), making it the more compelling value choice. Analysts rate Spok Holdings, Inc. (SPOK) a "Hold" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — LPSN or SPOK?
Over the past 5 years, Spok Holdings, Inc.
(SPOK) delivered a total return of +60. 8%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: SPOK returned +13. 2% versus LPSN's -97. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — LPSN or SPOK?
By beta (market sensitivity over 5 years), Spok Holdings, Inc.
(SPOK) is the lower-risk stock at 0. 42β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 388% more volatile than SPOK relative to the S&P 500.
04Which is growing faster — LPSN or SPOK?
By revenue growth (latest reported year), Spok Holdings, Inc.
(SPOK) is pulling ahead at 1. 5% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: LivePerson, Inc. grew EPS 45. 4% year-over-year, compared to 2. 7% for Spok Holdings, Inc.. Over a 3-year CAGR, SPOK leads at 1. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — LPSN or SPOK?
Spok Holdings, Inc.
(SPOK) is the more profitable company, earning 11. 4% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 11. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPOK leads at 14. 1% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — LPSN or SPOK?
In this comparison, SPOK (12.
2% yield) pays a dividend. LPSN does not pay a meaningful dividend and should not be held primarily for income.
07Is LPSN or SPOK better for a retirement portfolio?
For long-horizon retirement investors, Spok Holdings, Inc.
(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 12. 2% yield). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPOK: +13. 2%, LPSN: -97. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between LPSN and SPOK?
These companies operate in different sectors (LPSN (Technology) and SPOK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LPSN is a small-cap quality compounder stock; SPOK is a small-cap deep-value stock. SPOK pays a dividend while LPSN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.